1 story in the last 7 days
The latest insilico medicine news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks insilico medicine across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
Insilico Medicine and SK Biopharmaceuticals achieved an AI-powered drug discovery collaboration worth up to $2.5 billion for neuroimmune disorders. The partnership targets the development of new treatments using artificial intelligence. The deal was announced by the companies.
Summaries by ByteBrief